telmisartan has been researched along with Hyperplasia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cao, L; Cong, H; Hou, K; Wan, L; Wang, J; Yan, H; Zhao, C; Zhao, L | 1 |
| Haraguchi, G; Ishihara, T; Isobe, M; Kosuge, H; Maejima, Y; Okada, H; Saiki, H; Suzuki, J | 1 |
2 other study(ies) available for telmisartan and Hyperplasia
| Article | Year |
|---|---|
The effect of Telmisartan on the expression of connexin43 and neointimal hyperplasia in a rabbit iliac artery restenosis model.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Catheterization; Cell Proliferation; Connexin 43; Hyperplasia; Iliac Artery; Male; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Neointima; Rabbits; Telmisartan | 2019 |
Treatment with telmisartan attenuates graft arteriosclerosis in murine cardiac allografts.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Benzoates; Cell Division; Coronary Artery Disease; Cytokines; Graft Rejection; Heart Transplantation; Hyperplasia; Male; Mice; Mice, Inbred C57BL; Mice, Inbred Strains; Muscle, Smooth, Vascular; PPAR gamma; Telmisartan; Transplantation, Homologous; Tunica Media | 2010 |